Lessons from transgenic and knockout animals about noninsulin-dependent diabetes mellitus

Trends in Endocrinology and Metabolism

Volumn 7, Issue 9, 1996, Pages 311-319

  Patti, Mary Elizabeth ^a   Kahn, C Ronald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; INSULIN RECEPTOR;

GENE EXPRESSION REGULATION; GLUCOSE HOMEOSTASIS; INSULIN RELEASE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; TISSUE DISTRIBUTION;

EID: 0030296425     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(96)00154-3     Document Type: Short Survey

References (65)

1. Accili D, Drago J, Lee EJ, et al.: 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12:106-109.
2. Almind K, Biorbaek C, Vestergaard H, Hansen T, Echwald SM, Pedersen O: 1993. Amino acid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342:828-832.
3. Araki E, Lipes MA, Patti ME, et al.: 1994. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190.
4. Bali D, Svetlanov A, Lee HW, et al.: 1995. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem 270:21,464-21,467.
5. Benecke H, Flier JS, Rosenthal N, Siddle K, Klein HH, Moller DE: 1993. Muscle-specific expression of human insulin receptor in transgenic mice. Diabetes 42:206-212.
6. Bradley A, Evans M, Kaufman MH, Robertson E: 1984. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309:255-256.
7. Bronson SK, Smithies O: 1994. Altering mice by homologous recombination using embryonic stem cells. J Biol Chem 269:27,155-27,158.
8. Bruening JC, Winnay J, Bonner-Weir S, Accili D, Kahn CR: 1996. Creating polygenic models of insulin resistance and diabetes mellitus [abst]. J Invest Med 44:256A.
9. Celi FS, Silver K, Walston J, Knowler WC, Bogardus C, Shuldiner AR: 1995. Lack of IRS-1 codon 513 and 972 polymorphism in Pima Indians. J Clin Endocrinol Metab 80:2827-2829.
10. Chang PY, Benecke H, Le Marchand-Brustel Y, Lawitts J, Moller DE: 1994. Expression of a dominant-negative mutant human insulin receptor in the muscle of transgenic mice. J Biol Chem 269:16,034-16,040.
11. Chang PY, Goodyear LJ, Benecke H, Markuns JS, Moller DE: 1995a. Impaired insulin signaling in skeletal muscles from transgenic mice expressing kinase-deficient insulin receptors. J Biol Chem 270:12,593-12,600.
12. rsk, and p70 S6 kinase in skeletal muscle of normal and insulin-resistant mice. J Biol Chem 270: 29,928-29,935.
13. Clausen JO, Hansen T, Bjorbaek C, et al.: 1995. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 346:397-402.
14. D'Alessio DA, Verchere CB, Kahn SE, et al: 1994. Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes 43:1457-1461.
15. Deems RO, Evans JL, Deacon RW, et al.: 1994. Expression of human GLUT4 in mice results in increased insulin action. Diabetologia 37: 1097-1104.
16. De Koning EJP, Morris ER, Hofhuis FMA, et al.: 1994. Intra-and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 91:8467-8471.
17. Efrat S, Fleischer N, Hanahan D: 1990. Diabetes induced in male transgenic mice by expression of human H-ras oncoprotein in pancreatic β cells. Mol Cell Biol 10:1779-1783.
18. Efrat S, Leiser M, Wu YJ, et al.: 1994. Ribozyme-mediated attenuation of pancreatic β-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion. Proc Natl Acad Sci USA 91: 2051-2055.
19. Epstein PN, Overbeek PA, Means AR: 1989. Calmodulin-induced early-onset diabetes in transgenic mice. Cell 58:1067-1073.
20. Epstein PN, Boschero AC, Atwater I, Cai X, Overbeek PA: 1992. Expression of yeast hexokinase in pancreatic β cells of transgenic mice reduces blood glucose, enhances insulin secretion, and decreases diabetes. Proc Natl Acad Sci USA 89:12,038-12,042.
21. Ferrer J, Benito C, Gomis R: 1995. Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM. Diabetes 44:1369-1374.
22. Fox N, Schrementi J, Nishi M, et al.: 1995. Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM). Growth Regul 323:40-44.
23. Froguel P, Zouali H, Vionnet N, et al.: 1993. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med 328:697-702.
24. Gibbs EM, Stock JL, McCoid SC, et al.: 1995. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest 95:1512-1518.
25. Gnudi L, Tozzo E, Shepherd PR, Bliss JL, Kahn BB: 1995. High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance. Endocrinology 136:995-1002.
26. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH: 1980. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Nad Acad Sci USA 77:7380-7384.
27. Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA: 1995. Transgenic knockouts reveal a critical requirement for pancreatic β cell glucokinase in maintaining glucose homeostasis. Cell 83:69-78.
28. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K: 1994. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265: 103-106.
29. Gulve EA, Ren JM, Marshall BA, et al.: 1994. Glucose transport activity in skeletal muscles from transgenic mice overexpressing GLUT1: increased basal transport is associated with a defective response to diverse stimuli that activate GLUT4. J Biol Chem 269:18,366-18,370.
30. Hamann A, Benecke H, Le Marchand-Brustel Y, Susulic VS, Lowell BB, Flier JS: 1995. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44:1266-1273.
31. Hamann A, Flier JS, Lowell BB: 1996. Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 137:21-29.
32. Hoppener JWM, Verbeek JS, de Koning EJP, et al.: 1993. Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 36:1258-1265.
33. Houseknecht KL, Zhu AX, Gnudi L, et al.: 1996. Overexpression of H-Ras selectively in adipose tissue of transgenic mice: evidence for enhanced sensitivity to insulin. J Biol Chem 271:11347-11355.
34. Ikemoto S, Thompson KS, Itakura H, Lane MD, Ezaki O: 1995. Expression of an insulin-responsive glucose transporter (GLUT4) minigene in transgenic mice: effect of exercise and role in glucose homeostasis. Proc Natl Acad Sci USA 92:865-869.
35. Joshi RL, Lamothe B, Cordonnier N, et al.: 1996. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J 15:1542-1547.
36. Kahn CR: 1994. Insulin action, diabetogenes, and the cause of type II diabetes (Banting Lecture). Diabetes 43:1066-1084.
37. Kaku K, Province M, Permutt MA: 1989. Genetic analysis of obesity-induced diabetes associated with a limited capacity to synthesize insulin in C57BL/KS mice: evidence for polygenic control. Diabetologia 32:636-643.
38. Kato I, Takasawa S, Akabane A, et al.: 1995. Regulatory role of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in insulin secretion by glucose in pancreatic β cells: enhanced insulin secretion in CD38-expressing transgenic mice. J Biol Chem 270:30,045-30,050.
39. Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ: 1995. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377:151-155.
40. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Deeb SS: 1994. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest 94:1141-1146.
41. Lewis J, Yang B, Detloff P, Smithies O: 1996. Gene modification via "plug and socket" gene targeting. J Clin Invest 97:3-5.
42. Marban SL: 1992. Hyperinsulinemia precedes insulin resistance in a transgenic mouse model of Type II diabetes [abst]. Diabetes 41:145A.
43. Marban SL, Barr V, Roth J: 1990. Hyperinsulinemia in transgenic mice leads to insulin resistance, receptor down-regulation and glucose intolerance [abst]. Diabetes 39:59A.
44. Marin P, Rebuffe-Scrive M, Smith U, Bjorntorp P: 1987. Glucose uptake in human adipose tissue. Metabolism 36:1154-1160.
45. Marshall BA, Mueckler MM: 1994. Differential effects of GLUT-1 or GLUT-4 overexpression on insulin responsiveness in transgenic mice. Am J Physiol 267:E738-E744.
46. Marshall BA, Ren JM, Johnson DW, et al.: 1993. Germline manipulation of glucose homeostasis via alteration of glucose transporter levels in skeletal muscle. J Biol Chem 268:18,442-18,445.
47. iα2. Nature 379:840-843.
48. Mori H, Hashiramoto M, Kishimoto M, Kasuga M: 1995. Amino acid polymorphisms of the insulin receptor substrate-1 in Japanese non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 80:2822-2826.
49. Mueckler M, Kruse M, Strube M, Riggs AC, Chiu KC, Permutt MA. 1994. A mutation in the Glut2 glucose transporter gene of a diabetic patient abolishes transport activity. J Biol Chem 269:17,765-17,767.
50. Patti ME, Sun XJ, Bruning JC, et al.: 1995. 4PS/IRS-2 is the alternative substrate of the insulin receptor in IRS-1 deficient mice. J Biol Chem 270:24,670-24,673.
51. Rossetti L, Stenbit AE, Katz EB, et al.: 1996. Disruption of one allele of the murine GLUT4 gene causes marked resistance to the action of insulin [abst]. J Inv Med 44:265A.
52. Schaefer EM, Viard V, Morin J, et al.: 1994. A new transgenic mouse model of chronic hyperglycemia. Diabetes 43:143-152.
53. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB: 1993. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 269:22,243-22,248.
54. Shizuru J, Sarvetnick N: 1991. Transgenic models of diabetes mellitus. Trends Endocrinol Metab 3:97-104.
55. Tal M, Wu YJ, Leiser M, et al.: 1992. HRAS downregulates GLUT2 in beta cells of transgenic mice without affecting glucose homeostasis. Proc Natl Acad Sci USA 89:5744-5748.
56. Tamemoto H, Kadowaki T, Tobe K, et al.: 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-186.
57. Taylor SI: 1992. Lilly lecture: molecular mechanisms of insulin resistance-lessons from patients with mutations in the insulin receptor gene. Diabetes 41:1473-1490.
58. Terauchi Y, Sakura H, Yasuda K, et al.: 1995. Pancreatic β-cell-specific targeted disruption of glucokinase gene. J Biol Chem 270:30,253-30,256.
59. Tozzo E, Shepherd PR, Gnudi L, Kahn BB: 1995. Transgenic GLUT-4 overexpression in fat enhances glucose metabolism: preferential effect on fatty acid synthesis. Am J Physiol 268:E956-E964.
60. Treadway JL, Hargrove DM, Nardone NA, et al.: 1994. Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene. J Biol Chem 269:29,956-29,961.
61. Valera A, Pujol A, Pelegrin M, Bosch F: 1994a. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:9151-9154.
62. Valera A, Solanes G, Fernandez-Alvarez J, et al.: 1994b. Expression of GLUT-2 antisense RNA in β cells of transgenic mice leads to diabetes. J Biol Chem 269:28,543-28,546.
63. Verchere CB, D'Alessio DA, Palmiter RD, Kahn SE: 1994. Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro. Diabetologia 37:725-728.
64. Voss-McCowan ME, Xu B, Epstein PN: 1994. Insulin synthesis, secretory competence, and glucose utilization are sensitized by transgenic yeast hexokinase. J Biol Chem 269: 15,814-15,818.
65. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: 1990. Slow glucose removal rate and hyperinsulinemia are predictors of the risk of Type II diabetes in offspring of diabetic parents. Ann Intern Med 113:909-915. TEM